3-[(2-butyl-6,7-dichloro-2-cyclopentyl-1-hydroxy-1,3-dihydroinden-5-yl)oxy]cyclobutane-1-carboxylic acid
C23H30Cl2O4 — CID 155412531
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[(2-butyl-6,7-dichloro-2-cyclopentyl-1-hydroxy-1,3-dihydroinden-5-yl)oxy]cyclobutane-1-carboxylic acid
3-[(2-butyl-6,7-dichloro-2-cyclopentyl-1-hydroxy-1,3-dihydroinden-5-yl)oxy]cyclobutane-1-carboxylic acid (PubChem CID 155412531) has the molecular formula C23H30Cl2O4 and a molecular weight of 441.40 g/mol. Its IUPAC name is 3-[(2-butyl-6,7-dichloro-2-cyclopentyl-1-hydroxy-1,3-dihydroinden-5-yl)oxy]cyclobutane-1-carboxylic acid.
Molecular Properties
| Compound Name | 3-[(2-butyl-6,7-dichloro-2-cyclopentyl-1-hydroxy-1,3-dihydroinden-5-yl)oxy]cyclobutane-1-carboxylic acid |
|---|---|
| PubChem CID | 155412531 |
| Molecular Formula | C23H30Cl2O4 |
| Molecular Weight | 441.40 g/mol |
| Exact Mass | 440.15 |
| IUPAC Name | 3-[(2-butyl-6,7-dichloro-2-cyclopentyl-1-hydroxy-1,3-dihydroinden-5-yl)oxy]cyclobutane-1-carboxylic acid |
| SMILES | CCCCC1(C2CCCC2)Cc2cc(OC3CC(C(=O)O)C3)c(Cl)c(Cl)c2C1O |
| InChI | InChI=1S/C23H30Cl2O4/c1-2-3-8-23(15-6-4-5-7-15)12-14-11-17(19(24)20(25)18(14)21(23)26)29-16-9-13(10-16)22(27)28/h11,13,15-16,21,26H,2-10,12H2,1H3,(H,27,28) |
| InChIKey | ZGQUORIPCUFUMO-UHFFFAOYSA-N |
| XLogP | 6.19 |
| TPSA | 66.76 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 441.40 |
| LogP ≤ 5 | 6.19 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155412531 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.